INSIGHTS ON CRITICAL ENVIRONMENTS

• Activate Advanced Contamination Control Technology To Safeguard Your Cell Therapy

  The most common contamination risks in cell therapy manufacturing are open processes that leverage different products, inflexible instruments, labor intensive workflows, lack of in-line monitoring, and zero failure tolerance.

• Material Transfer Into A Cleanroom: How To Reduce Contamination Risk At Every Step

  Evaluate packaging integrity and master wiping techniques to prevent cleanroom contamination. Focus on surface coverage and controlled transfer paths to ensure consistent product safety and quality.

• Sourcing Pharmaceutical And Industrial Equipment In Auctions

  More and more industrial gear is hitting the auction block. Unlock significant savings by understanding the nuances of pharmaceutical and industrial equipment auctions.

• Enhancing Biological Indicators With Enzyme Indicators: A Complementary Approach

  Quantitative enzyme indicators complement biological indicators to deliver rapid, site-specific lethality data for VPHP decontamination validation.

• Confessions Of A Microbiologist: What I Wish I Had Known For Our Facility Shutdown

  11/17/2025

  Facility shutdowns often compromise contamination control strategies. Transitioning from manual cleaning to automated bio-decontamination ensures a more effective facility restart, eliminating persistent mold risks.

• Evaluating Carryover When Using A TOC Analyzer

  4/10/2026

  Accurate TOC results shouldn’t depend on sample order. See how low-level measurements remain reliable even after high-TOC analysis, helping reduce false positives and streamline decisions.

• The Hidden Threat To Product Purity: Neglected Seals In Synthesis Columns

  6/3/2025

  In biopharmaceutical manufacturing, seemingly minor components like seals can pose significant risks to product purity. Overlooking them can lead to contamination and costly delays.

• Why Compounding Pharma Manufacturers Should Evaluate BFS Systems

  12/5/2024

  Discover how BFS technology offers compounding pharmacies and 503B facilities enhanced sterility, reduced errors, cost savings, and superior product integrity for aseptic pharmaceutical manufacturing.

• Engineering Controls For Sterile Compounding — USP Requirements And Equipment Selection

  7/24/2026

  Aligning compounding operations with USP <797> and <800> requires an integrated control strategy. Discover key criteria for cleanroom equipment selection.